Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000)
- PMID: 12693558
- DOI: 10.1080/0036554021000027015
Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000)
Abstract
To characterize the clinical features of bacteraemia due to tribe Proteeae, 132 cases among 130 patients from 1991 to 2000 were analysed. The organisms included the Proteus species in 63 cases (P. mirabilis in 41, P. penneri in 2 and P. vulgaris in 20), the Providencia species in 8 (P. rettgeri in 3 and P. stuartii 5) and Morganella morganii in 61. Morganella bacteraemia occurred more frequently in the hospital (70.5%). Biliary and hepatic diseases were predominant in cases with Morganella bacteraemia while cardiovascular, urological and neurological diseases were more common in cases with Proteus bacteraemia. Biliary drainage catheters had more frequently been placed in cases with Morganella bacteraemia (39.3%, p < 0.001), and urinary catheters more frequently in cases with Proteus bacteraemia (17.5%). Biliary infection was most common in cases with Morganella bacteraemia (49.2%), while urinary tract infection (UTI) was most common in cases with Proteus bacteraemia (47.6%). Mortality directly related to bacteraemia due to tribe Proteeae was 20.8% (22.6, 50.0 and 15.0% for Proteus, Providencia and Morganella bacteraemia, respectively). In conclusion, Morganella bacteraemia was most frequently associated with biliary infection, while Proteus bacteraemia was most frequently with UTI. Providencia bacteraemia was relatively uncommon and it can be associated with infections other than UTI.
Similar articles
-
Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region.Clin Microbiol Infect. 2007 Jul;13(7):683-8. doi: 10.1111/j.1469-0691.2007.01715.x. Epub 2007 Apr 2. Clin Microbiol Infect. 2007. PMID: 17403132
-
Antimicrobial susceptibility and distribution of extended-spectrum β-lactamases, AmpC β-lactamases and carbapenemases among Proteus, Providencia and Morganella isolated from global hospitalised patients with intra-abdominal and urinary tract infections: Results of the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2008-2011.J Glob Antimicrob Resist. 2020 Sep;22:398-407. doi: 10.1016/j.jgar.2020.04.011. Epub 2020 Apr 18. J Glob Antimicrob Resist. 2020. PMID: 32311502
-
Occurrence and pathogenic role of Morganella-Proteus-Providencia group bacteria in human feces.J Clin Microbiol. 1986 Feb;23(2):404-5. doi: 10.1128/jcm.23.2.404-405.1986. J Clin Microbiol. 1986. PMID: 3517057 Free PMC article.
-
Classification, identification, and clinical significance of Proteus, Providencia, and Morganella.Clin Microbiol Rev. 2000 Oct;13(4):534-46. doi: 10.1128/CMR.13.4.534. Clin Microbiol Rev. 2000. PMID: 11023955 Free PMC article. Review.
-
Providencia stuartii: a common cause of antibiotic-resistant bacteriuria in patients with long-term indwelling catheters.Rev Infect Dis. 1986 Jan-Feb;8(1):61-7. doi: 10.1093/clinids/8.1.61. Rev Infect Dis. 1986. PMID: 3081988 Review.
Cited by
-
Antimicrobial Resistance and Virulence Factors of Proteus mirabilis Isolated from Dog with Chronic Otitis Externa.Pathogens. 2022 Oct 21;11(10):1215. doi: 10.3390/pathogens11101215. Pathogens. 2022. PMID: 36297273 Free PMC article.
-
Clinical manifestations and prognostic factors of Morganella morganii bacteremia.Eur J Clin Microbiol Infect Dis. 2015 Feb;34(2):231-6. doi: 10.1007/s10096-014-2222-8. Epub 2014 Aug 9. Eur J Clin Microbiol Infect Dis. 2015. PMID: 25107625
-
A Rare Opportunist, Morganella morganii, Decreases Severity of Polymicrobial Catheter-Associated Urinary Tract Infection.Infect Immun. 2019 Dec 17;88(1):e00691-19. doi: 10.1128/IAI.00691-19. Print 2019 Dec 17. Infect Immun. 2019. PMID: 31611275 Free PMC article.
-
Transposon Insertion Site Sequencing of Providencia stuartii: Essential Genes, Fitness Factors for Catheter-Associated Urinary Tract Infection, and the Impact of Polymicrobial Infection on Fitness Requirements.mSphere. 2020 May 27;5(3):e00412-20. doi: 10.1128/mSphere.00412-20. mSphere. 2020. PMID: 32461277 Free PMC article.
-
Solubility Enhancement, Formulation Development, and Antibacterial Activity of Xanthan-Gum-Stabilized Colloidal Gold Nanogel of Hesperidin against Proteus vulgaris.Gels. 2022 Oct 14;8(10):655. doi: 10.3390/gels8100655. Gels. 2022. PMID: 36286156 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical